Benefits of supplemented preterm formulas on insulin sensitivity and body composition after discharge from the neonatal intensive care unit
Author
dc.contributor.author
Pittaluga, Enrica
Author
dc.contributor.author
Vernal, Patricia
Author
dc.contributor.author
Llanos, Adolfo
Author
dc.contributor.author
Vega, Susana
Author
dc.contributor.author
Henrriquez, Maria Teresa
Author
dc.contributor.author
Morgues, Monica
Author
dc.contributor.author
Escobar, Marisol
Author
dc.contributor.author
Diaz, Alexis
Author
dc.contributor.author
Standen, Jane
Author
dc.contributor.author
Moncada, Paulina
Author
dc.contributor.author
Arriagada, Marina
Author
dc.contributor.author
Rodriguez, Lorena
Author
dc.contributor.author
Mericq, Verónica
Admission date
dc.date.accessioned
2019-03-11T13:02:33Z
Available date
dc.date.available
2019-03-11T13:02:33Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Journal of Pediatrics, Volumen 159, Issue 6, 2018,
Identifier
dc.identifier.issn
00223476
Identifier
dc.identifier.issn
10976833
Identifier
dc.identifier.other
10.1016/j.jpeds.2011.06.002
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165396
Abstract
dc.description.abstract
Objective: To evaluate body composition and fasting insulin level in preterm infants receiving preterm formulas (higher protein plus docosahexaenoic acid) for longer periods compared with a recent historical cohort receiving these formulas for shorter periods. Study design: A total of 95 infants fed preterm formula for 6 months or longer (postdischarge formula group) and 87 infants fed preterm formula only during their hospital stay (hospital formula group) were included in this arm of the study. Results: Bone mineral density, content, and lean mass were not different at 1 year and 2 years. However, in the postdischarge formula group, total fat mass (%) was lower by the second year (19.3% ± 5.3% vs 21.7% ± 4.2%; P <.01), trunk fat was lower by the first year (14.7% ± 5.0% vs 16.9% ± 4.9%; P <.005) and at the second year (14.1% ± 5.7% vs 17.2% ± 4.7%; P <.001), and fasting insulin was lower by the first year (13.2% ± 7.1% vs 17.2% ± 13.6% mIU/L; P =.06) and at the second year (13.6% ± 6